3139 results for «966»
3139 results
The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 1)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...
Multivessel disease revascularisation: balancing the risk
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jean Fajadet, Thomas Cuisset, Bruno Farah, Marek Grygier, Maciej Lesiak and Sylwia Iwanczyk in order to understand the selection of PCI for multivessel disease patients, to demonstrate the best treatment strategy for patients presenting with multivessel disease, and to discuss DAPT strategy in multivessel...
The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in bifurcation lesions:
- EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
- Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
MagicTouch sirolimus coated balloon continues to be the choice of treatment for CAD
19 May 2021 – From EuroPCR 2021
Watch this session presented by Antonio Colombo, Aloke Finn, Sandeep Basavarajaiah, Gianluca Caiazzo and Bernardo Cortese in order to know where to use a DCB in today's clinical practice, to learn about real-world case-based experience and interesting data presentation from various registries and clinical studies, and to understand the technology...
Current status of renal denervation techniques for the treatment of hypertension (Part 2)
19 May 2021 – From EuroPCR 2021
Watch this session if you want to review the up-to-date indications, device selection and procedural techniques for renal denervation.
This session was originally presented during EuroPCR 2021.
Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4
19 May 2021 – From EuroPCR 2021
Watch this session presented by Francesco Maisano, Philipp Lurz, Fabien Praz, Patrizio Lancellotti and Georg Nickenig in order to learn about patient diagnosis and selection for tricuspid transcatheter treatment with TriClip, about latest clinical data supporting TriClip therapy, and about real life experience and attest product innovation: TriClip G4.
EuroPCR 2021 Hotlines / Late-Breaking Trials in imaging: CASTLE, CLI-OPCI, FORZA, ILUMIEN-IV, CLI-OPCI II, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- A randomized study comparing imaging guided implantation of Orsiro and Xience: the CASTLE study
- Impact of different optimal stent implantation definitions in OCT-guide PCI
- Risk-stratification in ACS by comprehensive morphofunctional assessment with OCT
- 7.5 years follow-up after OCT-guided PCI: report...
New horizons in tricuspid therapy, the TricValve solution
19 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Haude, Christoph Naber, Mohamed Abdel-Wahab, Mohd Ghazi Azmee, Yahaya Shaiful Azmi, Katharina Kiss and Ignacio Amat Santos in order to learn about the TricValve system's approach to tricuspid regurgitation and right heart disease, to understand how this new generation of tricuspid valve system may...
EuroPCR 2021 Hotlines / Late-Breaking Trials in physiology: FAST II, TARGET FFR, P3, OLV Pullback, France PCI, and more!
27 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in imaging:
- Angiography based Fractional Flow Reserve: the FAST II trial
- Instantaneous wave-free ratio for the assessment of nonculprit lesions
- Capacity of the PPG to predict functional revascularisation
- Clinical impact of FFR guided PCI
EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in ACS:
- COOL AMI EU pivotal trial
- Complete versus incomplete revascularization in NSTEMI patients
- Non-hyperaemic IMRangio and long-term clinical outcome in STEMI
PCI in a patient with prior TAVI - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.
This session was originally presented during EuroPCR 2021.
Percutaneous mitral treatment: repair - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand patient selection for percutaneous mitral treatment, to select percutaneous valve repair or replacement and to learn tips and tricks in percutaneous valve treatment.
This session was originally presented during EuroPCR 2021.
How does Paradise renal denervation fit into hypertension treatment management?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Felix Mahfoud, Philipp Lurz, Konstantinos Tsioufis and Joachim Weil in order to understand the ultrasound-based renal denervation procedure and summary of the latest clinical data, to review consensus statements and guidelines for the renal denervation therapy today, and to hear expert perspectives on how to establish...
Percutaneous mitral treatment: replacement
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand patient selection for percutaneous mitral treatment, to select percutaneous valve repair or replacement, and to learn tips and tricks in percutaneous valve treatment.
This session was originally presented during EuroPCR 2021.
Paclitaxel and sirolimus coated balloons: create evidence before claims
20 May 2021 – From EuroPCR 2021
Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons...
Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme
20 May 2021 – From EuroPCR 2021
Watch this session presented by Simon Kennon, Olivier Darremont, Helene Eltchaninoff, Derk Frank, Sandra Lauck and Francesco Saia in order to improve access to high quality of care with safe early discharge for selected patients in Europe, to identify strategies to reduce hospital stay and optimise TAVI programmes for...
EuroPCR 2021 - Innovations in peripheral and structural interventions
18 May 2021 – From EuroPCR 2021
In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in BRS/BVS:
- Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
- France Absorb registry: final five years follow-up
- A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
- Three-year follow-up of the prospective bvs stemi strategy-it study
- Final five-year results of AIDA trial
- Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
